Latest News

Welltower Inc (NYSE:WELL) Expected to Announce Quarterly Sales of $1.25 Billion

Welltower Inc (NYSE:WELL) Expected to Announce Quarterly Sales of $1.25 Billion

Analysts forecast that Welltower Inc (NYSE:WELL) will announce sales of $1.25 billion for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Welltower’s earnings, with the lowest sales estimate coming in at $1.23 billion and the highest estimate coming in at $1.28 billion. Welltower reported sales of $1.24 billion during the same quarter last […]

by × December 6, 2019 ×
Kornit Digital Ltd (NASDAQ:KRNT) Expected to Announce Quarterly Sales of $48.49 Million

Kornit Digital Ltd (NASDAQ:KRNT) Expected to Announce Quarterly Sales of $48.49 Million

Equities analysts expect Kornit Digital Ltd (NASDAQ:KRNT) to post sales of $48.49 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Kornit Digital’s earnings, with estimates ranging from $48.40 million to $48.57 million. Kornit Digital posted sales of $37.79 million in the same quarter last year, which would indicate a positive year-over-year growth rate of […]

by × December 6, 2019 ×
$59.96 Million in Sales Expected for Glaukos Corp (NYSE:GKOS) This Quarter

$59.96 Million in Sales Expected for Glaukos Corp (NYSE:GKOS) This Quarter

Equities analysts predict that Glaukos Corp (NYSE:GKOS) will report $59.96 million in sales for the current fiscal quarter, according to Zacks. Three analysts have issued estimates for Glaukos’ earnings. The highest sales estimate is $60.50 million and the lowest is $59.48 million. Glaukos posted sales of $54.08 million during the same quarter last year, which suggests a positive year-over-year growth […]

by × December 6, 2019 ×
Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Expected to Announce Quarterly Sales of $5.20 Million

Pieris Pharmaceuticals Inc (NASDAQ:PIRS) Expected to Announce Quarterly Sales of $5.20 Million

Equities analysts expect Pieris Pharmaceuticals Inc (NASDAQ:PIRS) to post sales of $5.20 million for the current quarter, Zacks reports. Two analysts have provided estimates for Pieris Pharmaceuticals’ earnings. The lowest sales estimate is $3.29 million and the highest is $7.10 million. Pieris Pharmaceuticals reported sales of $4.91 million in the same quarter last year, which would suggest a positive year […]

by × December 6, 2019 ×
Sunrun Inc (NASDAQ:RUN) Expected to Post Quarterly Sales of $217.35 Million

Sunrun Inc (NASDAQ:RUN) Expected to Post Quarterly Sales of $217.35 Million

Brokerages forecast that Sunrun Inc (NASDAQ:RUN) will report $217.35 million in sales for the current fiscal quarter, according to Zacks. Two analysts have made estimates for Sunrun’s earnings, with the highest sales estimate coming in at $256.20 million and the lowest estimate coming in at $178.50 million. Sunrun posted sales of $240.12 million in the same quarter last year, which […]

by × December 6, 2019 ×